Home > Signaling Pathways>Neuronal Signaling>COX >Oxaprozin (Oxaprozinum; Wy21743)
Oxaprozin (Oxaprozinum; Wy21743)

This product is for research use only, not for human use. We do not sell to patients.

Oxaprozin (Oxaprozinum; Wy21743)
For small sizes, please check our retail website as below: www.invivochem.com
Size Price Stock
25g$650Check With Us
50g$980Check With Us
100g$1470Check With Us

Cat #: V1065 CAS #: 21256-18-8 Purity ≥ 98%

Description: Oxaprozin (Oxaprozinum, DL-8280, WY-21743; DR-3355, Hoe-280, ORF-28489, Ru-43280, Tarivid) is a potent nonsteroidal anti-inflammatory drug (NSAID) with analgesic and antipyretic properties.

References: Ottonello L, et al. Delayed apoptosis of human monocytes exposed to immune complexes is reversed byoxaprozin: role of the Akt/IkappaB kinase/nuclear factor kappaB pathway. Br J Pharmacol. 2009 May;157(2):294-306.

Top Publications Citing Invivochem Products
Publications Citing InvivoChem Products

Product Promise

Promise
Molecular Weight (MW)293.32
Molecular FormulaC18H15NO3
CAS No.21256-18-8
Storage-20℃ for 3 years in powder formrr
-80℃ for 2 years in solvent
Solubility In VitroDMSO: 59 mg/mL (201.1 mM)rr
Water: <1 mg/mLrr
Ethanol: 27 mg/mL (92.0 mM)
SMILES CodeCC1COC2=C3N1C=C(C(O)=O)C(C3=CC(F)=C2N4CCN(C)CC4)=O
SynonymsWY21743; Oxaprozin, Oxaprozinum, DL-8280, WY-21743; WY 21743; DR-3355, Hoe-280, ORF-28489, Ru-43280, Tarivid
ProtocolIn VitroOxaprozin induces apoptosis in a dose-dependent manner. Oxaprozin increases caspase-3 activity in the activated but not in the resting condition. NF-κB activation is inhibited by Oxaprozin (50 μM). Oxaprozin inhibits activation of the IKK system induced by the reagent IκBα
These protocols are for reference only. InvivoChem does not independently validate these methods.
Preparing Stock Solutions
Solvent volume to be added Mass (the weight of a compound)
Mother liquor concentration 1mg5mg10mg20mg
1mM3.4092 mL17.0462 mL34.0925 mL68.1849 mL
5mM0.6818 mL3.4092 mL6.8185 mL13.6370 mL
10mM0.3409 mL1.7046 mL3.4092 mL6.8185 mL
20mM0.1705 mL0.8523 mL1.7046 mL3.4092 mL
Quality Control Documentation
The molarity calculator equation
Mass(g) = Concentration(mol/L) × Volume(L) × Molecular Weight(g/mol)
Mass
=
Concentration
×
Volume
×
Molecular Weight*
The dilution calculator equation
Concentration(start) × Volume(start) = Concentration(final) × Volume(final)

This equation is commonly abbreviated as: C1 V1 = C2 V2

Concentration(start)
C1
×
Volume(start)
V1
=
Concentration(final)
C2
×
Volume(final)
V2
Step One: Enter information below
Dosage mg/kg Average weight of animals g Dosing volume per animal µL Number of animals
Step Two: Enter the in vivo formulation
%DMSO + % + %Tween 80 + %ddH2O

Calculation Results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in µL DMSO(Master liquid concentration mg/mL) ,Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation: Take µL DMSO master liquid, next add µL PEG300, mix and clarify, next add µL Tween 80,mix and clarify, next add µL ddH2O,mix and clarify.
Note:
  • (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
  • (2) Be sure to add the solvent(s) in order.